Just as clinical trials of a widely heralded cancer treatment are about to be expanded, two groups report that they couldn't get it to work, indicating again how fickle and mysterious the compound remains
No takes yet. Share an insight, caveat, or question.
Eliot Marshall (2002) studied this question.